Compare PTCT & LBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | LBRT |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | 2006 | 2017 |
| Metric | PTCT | LBRT |
|---|---|---|
| Price | $69.14 | $27.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $80.65 | $24.00 |
| AVG Volume (30 Days) | 915.0K | ★ 4.7M |
| Earning Date | 05-05-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 7.78 | 0.89 |
| Revenue | $264,734,000.00 | ★ $4,006,116,000.00 |
| Revenue This Year | N/A | $0.07 |
| Revenue Next Year | $19.30 | $7.91 |
| P/E Ratio | ★ $8.71 | $31.57 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $9.50 |
| 52 Week High | $87.50 | $32.40 |
| Indicator | PTCT | LBRT |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 45.33 |
| Support Level | $64.00 | $26.72 |
| Resistance Level | $69.23 | $28.95 |
| Average True Range (ATR) | 2.24 | 1.48 |
| MACD | 0.57 | -0.47 |
| Stochastic Oscillator | 81.53 | 14.26 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.